Cervical Cancer Vanishes in Young English Women

In a historic first, England recorded no deaths from cervical cancer among women aged 20-24 between 2008 and 2024. This achievement is strongly linked to the HPV vaccine, first offered to schoolgirls nearly two decades prior. Despite declining screening participation in these cohorts, vaccination remains the sole plausible explanation for this outcome.

Similar success is observed in Scotland and Australia, where HPV vaccination programs have led to a dramatic reduction in invasive cervical cancer cases. Australia, in particular, aims to be the first nation to eliminate cervical cancer as a public health concern. The human papillomavirus (HPV), responsible for nearly all cervical cancers, can be prevented through vaccination.

The World Health Organization has established ambitious 2030 targets for global cervical cancer elimination: 90% HPV vaccination for girls, 70% screening for women, and 90% treatment for affected individuals. While Australia is nearing these goals, India faces significant challenges, with low screening rates and a high burden of cervical cancer deaths.

India has recently begun a national HPV vaccination rollout for 14-year-old girls, leveraging its robust immunization system. However, experts emphasize that vaccination alone is insufficient. Expanding screening programs, ideally using HPV testing, and strengthening treatment pathways are crucial to prevent deaths in older women. Public confidence in vaccination also needs careful management to overcome misconceptions.